Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001401914-22-000032
Filing Date
2022-03-31
Accepted
2022-03-31 16:09:25
Documents
78
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K dare-20211231.htm   iXBRL 10-K 2046316
2 EX-4.2 ex42_10kx2021.htm EX-4.2 111884
3 EX-21.1 dare-20211231xex211.htm EX-21.1 4115
4 EX-23.1 dare-20211231xex231.htm EX-23.1 3414
5 EX-31.1 dare-20211231xex311.htm EX-31.1 7983
6 EX-31.2 dare-20211231xex312.htm EX-31.2 7990
7 EX-32.1 dare-20211231xex321.htm EX-32.1 4033
8 EX-32.2 dare-20211231xex322.htm EX-32.2 3888
14 dare-20211231_g1.jpg GRAPHIC 130914
15 dare-20211231_g2.jpg GRAPHIC 98413
  Complete submission text file 0001401914-22-000032.txt   8473557

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dare-20211231.xsd EX-101.SCH 60725
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dare-20211231_cal.xml EX-101.CAL 60501
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dare-20211231_def.xml EX-101.DEF 271138
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dare-20211231_lab.xml EX-101.LAB 671458
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dare-20211231_pre.xml EX-101.PRE 436730
72 EXTRACTED XBRL INSTANCE DOCUMENT dare-20211231_htm.xml XML 953762
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

EIN.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36395 | Film No.: 22792532
SIC: 2834 Pharmaceutical Preparations